# Treace Medical Concepts Reports First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/TMCI/treace-medical-concepts-reports-first-quarter-2026-financial-results
Ticker: TMCI
Company: Treace Medical Concepts
Source: Treace Medical Concepts
Published: 2026-05-08 11:05 EST
Original Source URL: https://investors.treace.com
## Summary

PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the

## Article Body
PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the
## Recent Company News
- 2026-05-08 11:05 EST — [Treace Medical Concepts Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TMCI/treace-medical-concepts-reports-first-quarter-2026-financial-results) — Source: Treace Medical Concepts
- 2026-04-24 11:05 EST — [Treace to Report First Quarter 2026 Financial Results on May 8, 2026](https://biopharmsignal.com/news/TMCI/treace-to-report-first-quarter-2026-financial-results-on-may-8-2026) — Source: Treace Medical Concepts
- 2026-04-07 13:04 EST — [Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System](https://biopharmsignal.com/news/TMCI/treace-announces-first-surgical-cases-with-the-superbitetm-compression-screw-system) — Source: Treace Medical Concepts
- 2026-02-27 12:05 EST — [Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results](https://biopharmsignal.com/news/TMCI/treace-medical-concepts-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: Treace Medical Concepts
- 2026-02-24 12:05 EST — [Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference](https://biopharmsignal.com/news/TMCI/treace-highlights-new-product-innovations-and-updated-positive-clinical-study-data-at-the-2026-acfas-annual-scientific-conference) — Source: Treace Medical Concepts
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)